Interview with Craig Moore, Director, Hahn Healthcare
Can you outline the significance of the current PBS to the industry and in particular the impact it has on service providers to the industry such as Hahn? As service…
Address: Level 7, 50 Berry Street
North Sydney NSW 2060
Tel: 02 9959 5533
Web: http://www.hahnhealthcare.com.au/default.aspx
Hahn Healthcare combines innovative solutions and world-class services with market insight to create value in your business.
Hahn Healthcare offers clients access to: the highest quality people, industry leading solutions, innovative services, and new market opportunities.
Founded in 1994, Hahn Healthcare is a trusted partner with a reputation for excellence.
Innovative solutions. Market insight. Trusted Partnerships.
As a market leader, Hahn Healthcare is a trusted partner of key decision makers in the Australian pharmaceutical and medical device industries.
We are uniquely positioned to identify partner organisations and market opportunities for global healthcare products, including pharmaceutical and medical devices.
Our team partners with international companies to deliver global solutions locally. We provide strategic advice based on deep industry knowledge and create an access point to the Australian market.
Hahn Healthcare helps international companies reduce risk, manage regulatory requirements and create new revenue streams by facilitating the delivery of global solutions to the Australian marketplace.
Hahn Healthcare is committed to excellence. We build partnerships based on integrity, mutual respect and trust. We are transparent, accountable and operate according to the highest professional standards.
Can you outline the significance of the current PBS to the industry and in particular the impact it has on service providers to the industry such as Hahn? As service…
Would you begin by outlining the key milestones & achievements of the NHMRC in the past four years? The first point is the development of our initiatives on an international…
Would you please introduce The Pharmacy Guild to our readers, giving an insight in its function and its membership? We are the premium body representing community pharmacies in Australia, about…
Earlier this year the company set a crucial step in its internationalization strategy with the acquisition of Ascent. Would you outline the significance of the acquisition within Watson’s global expansion…
We last met you in 2008 as Chair of the Pharmaceuticals Industry Council (PIC), which set itself the goal of doubling the levels of exports, R&D investment, manufacturing, value-added activities,…
Would you outline the commitment of the Ministry to foster a positive business environment for the Australian pharmaceutical industry to prosper? Issues faced by the pharmaceutical industry are not unlike…
You were appointed last year with a specialized portfolio reflecting some of the key priorities on the country’s health care agenda. Would you begin by outlining your mission for your…
You returned to Australia a year ago after spending eight years in Europe with the company. In your view, what were the key changes in the Australian market? Looking at…
As a general medical practitioner with a long experience in the pharmaceutical industry including public policy, advertising, marketing and regulatory issues and a post graduate training in traditional Chinese medicine,…
In trying to be an effective association and positively influence the environment for your members, what have been the main achievements and milestones since you were appointed in 2008? We…
Please introduce Nucleus Network and the role it plays in the Australian pharmaceutical sector. Nucleus Network is an early-phase clinical research business, and is somewhat unique, as it is a…
As a biopharmaceutical company, how have the PBS reforms affected Celgene? Celgene looks at the PBS reforms more positively than negatively. As a company with a smaller product portfolio of…
To begin, would you please introduce GMIA to Pharmaceutical Executive readers? The GMIA is an industry organization. Its six members are: Alphapharm, Apotex, Genepharm, Hospira, Sandoz and Sigma. The GMiA…
See our Cookie Privacy Policy Here
